1. Home
  2. HZO vs MNPR Comparison

HZO vs MNPR Comparison

Compare HZO & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$24.83

Market Cap

550.9M

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$70.61

Market Cap

531.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
MNPR
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
550.9M
531.6M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
HZO
MNPR
Price
$24.83
$70.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$34.00
$97.83
AVG Volume (30 Days)
300.2K
194.6K
Earning Date
01-22-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$2.11
N/A
Revenue Next Year
$4.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$21.00
52 Week High
$33.28
$105.00

Technical Indicators

Market Signals
Indicator
HZO
MNPR
Relative Strength Index (RSI) 52.61 41.11
Support Level $24.28 $64.25
Resistance Level $25.49 $74.34
Average True Range (ATR) 0.99 4.79
MACD -0.01 -0.53
Stochastic Oscillator 34.45 31.45

Price Performance

Historical Comparison
HZO
MNPR

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: